1.
Managing Menopausal Symptoms and Associated Clinical Issues in Breast Cancer Survivors
by Santen, Richard J
The journal of clinical endocrinology and metabolism, 2017, Vol.102 (10), p.3647-3661
2.
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
by Santen, Richard J
The journal of clinical endocrinology and metabolism, 2010, Vol.95 (7_supplement_1), p.s1-s66
3.
Systemic estradiol levels with low-dose vaginal estrogens
by Santen, Richard J
Menopause (New York, N.Y.), 2020, Vol.27 (3), p.361-370
4.
Effects of the Conjugated Equine Estrogen/Bazedoxifene Tissue-Selective Estrogen Complex (TSEC) on Mammary Gland and Breast Cancer in Mice
by Song, Yan
Endocrinology (Philadelphia), 2012, Vol.153 (12), p.5706-5715
5.
Adenosine monophosphate activated protein kinase (AMPK), a mediator of estradiol-induced apoptosis in long-term estrogen deprived breast cancer cells
by Chen, Haiyan
Apoptosis (London), 2015, Vol.20 (6), p.821-830
6.
Estrogens and Their Genotoxic Metabolites Are Increased in Obese Prepubertal Girls
by Mauras, Nelly
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (6), p.2322-2328
7.
Estrogen Signaling via a Linear Pathway Involving Insulin-Like Growth Factor I Receptor, Matrix Metalloproteinases, and Epidermal Growth Factor Receptor to Activate Mitogen-Activat...
by Song, Robert X.-D
Endocrinology (Philadelphia), 2007, Vol.148 (8), p.4091-4101
8.
Estrogen Stimulation of Cell Migration Involves Multiple Signaling Pathway Interactions
by Li, Yan
Endocrinology (Philadelphia), 2010, Vol.151 (11), p.5146-5156
9.
Use of cardiovascular age for assessing risks and benefits of menopausal hormone therapy
by Santen, Richard J
Menopause (New York, N.Y.), 2017, Vol.24 (5), p.589-595
10.
Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline
by Stuenkel, Cynthia A
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (11), p.3975-4011
11.
History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target
by Santen, R. J
Endocrine reviews, 2009, Vol.30 (4), p.343-375
12.
Effect of Endocrine Therapies on Bone in Breast Cancer Patients
by Santen, R. J
The journal of clinical endocrinology and metabolism, 2011, Vol.96 (2), p.308-319
13.
Insights into Mentorship for Endocrinologists
by Eggleston, Emma
The journal of clinical endocrinology and metabolism, 2012, Vol.97 (11), p.3891-3896
14.
Mechanisms of Resistance to Structurally Diverse Antiestrogens Differ under Premenopausal and Postmenopausal Conditions: Evidence from in Vitro Breast Cancer Cell Models
by Fan, Ping
Endocrinology (Philadelphia), 2009, Vol.150 (5), p.2036-2045
15.
Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices
by Harvey, Jennifer A
Menopause (New York, N.Y.), 2008, Vol.15 (1), p.67-73
16.
Inhibitory Effects of a Bazedoxifene/Conjugated Equine Estrogen Combination on Human Breast Cancer Cells In Vitro
by Song, Yan
Endocrinology (Philadelphia), 2013, Vol.154 (2), p.656-665
17.
Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells
by JENG, Meei-Huey
Breast cancer research and treatment, 2000, Vol.62 (3), p.167-175
18.
Response to the Letter by Labrie et al
by Demers, Laurence M
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (9), p.L88-L88
19.
Career Advancement: Meeting the Challenges Confronting the Next Generation of Endocrinologists and Endocrine Researchers
by Santen, Richard J
The journal of clinical endocrinology and metabolism, 2016, Vol.101 (12), p.4512-4520
20.
Current and Evolving Approaches to Individualizing Estrogen Receptor-Based Therapy for Menopausal Women
by Santen, Richard J
The journal of clinical endocrinology and metabolism, 2014, Vol.99 (3), p.733-747
